Your browser doesn't support javascript.
loading
Extended exome sequencing identifies BACH2 as a novel major risk locus for Addison's disease.
Eriksson, D; Bianchi, M; Landegren, N; Nordin, J; Dalin, F; Mathioudaki, A; Eriksson, G N; Hultin-Rosenberg, L; Dahlqvist, J; Zetterqvist, H; Karlsson, Å; Hallgren, Å; Farias, F H G; Murén, E; Ahlgren, K M; Lobell, A; Andersson, G; Tandre, K; Dahlqvist, S R; Söderkvist, P; Rönnblom, L; Hulting, A-L; Wahlberg, J; Ekwall, O; Dahlqvist, P; Meadows, J R S; Bensing, S; Lindblad-Toh, K; Kämpe, O; Pielberg, G R.
Afiliação
  • Eriksson D; Department of Medicine (Solna), Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Bianchi M; Department of Endocrinology, Metabolism and Diabetes Karolinska University Hospital, Stockholm, Sweden.
  • Landegren N; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Nordin J; Department of Medicine (Solna), Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Dalin F; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Mathioudaki A; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Eriksson GN; Department of Medicine (Solna), Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Hultin-Rosenberg L; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Dahlqvist J; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Zetterqvist H; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Karlsson Å; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Hallgren Å; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Farias FH; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Murén E; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Ahlgren KM; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Lobell A; Department of Medicine (Solna), Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Andersson G; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Tandre K; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Dahlqvist SR; Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Söderkvist P; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Rönnblom L; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Hulting AL; Department of Animal Breeding and Genetics, Swedish University of Agricultural Sciences, Uppsala, Sweden.
  • Wahlberg J; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Ekwall O; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Dahlqvist P; Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
  • Meadows JR; Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Bensing S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Lindblad-Toh K; Department of Endocrinology, Department of Medical and Health Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
  • Kämpe O; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Pielberg GR; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
J Intern Med ; 280(6): 595-608, 2016 12.
Article em En | MEDLINE | ID: mdl-27807919
ABSTRACT

BACKGROUND:

Autoimmune disease is one of the leading causes of morbidity and mortality worldwide. In Addison's disease, the adrenal glands are targeted by destructive autoimmunity. Despite being the most common cause of primary adrenal failure, little is known about its aetiology.

METHODS:

To understand the genetic background of Addison's disease, we utilized the extensively characterized patients of the Swedish Addison Registry. We developed an extended exome capture array comprising a selected set of 1853 genes and their potential regulatory elements, for the purpose of sequencing 479 patients with Addison's disease and 1394 controls.

RESULTS:

We identified BACH2 (rs62408233-A, OR = 2.01 (1.71-2.37), P = 1.66 × 10-15 , MAF 0.46/0.29 in cases/controls) as a novel gene associated with Addison's disease development. We also confirmed the previously known associations with the HLA complex.

CONCLUSION:

Whilst BACH2 has been previously reported to associate with organ-specific autoimmune diseases co-inherited with Addison's disease, we have identified BACH2 as a major risk locus in Addison's disease, independent of concomitant autoimmune diseases. Our results may enable future research towards preventive disease treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Addison / Fatores de Transcrição de Zíper de Leucina Básica / Exoma Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: J Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Addison / Fatores de Transcrição de Zíper de Leucina Básica / Exoma Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: J Intern Med Assunto da revista: MEDICINA INTERNA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia